Adds company news, updates futures
July 14 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Monday, with futures FFIc1 down 0.2%.
* ASHMORE: Emerging markets-focused wealth manager Ashmore ASHM.L reported an increase in its fourth-quarter assets under management, driven by fund inflows into equities.
* GSK: British drugmaker GSK GSK.L said it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to adults under the age of 50 at a higher risk of the disease.
* ASTRAZENECA: AstraZeneca AZN.L said its drug Baxdrostat met all the main and secondary goals of a late-stage study in patients with uncontrolled or treatment resistant high blood pressure, or hypertension.
* EMISSIONS: British finance minister Rachel Reeves will task regulators this week with lowering barriers to businesses seeking to cut their emissions, in a major speech she is to give to the financial services sector, a government source told Reuters on Monday.
* PHARMACEUTICALS: Britain said it would strike an agreement with Vietnam to make it easier for pharmaceutical firms to sell UK-made medicines in the Southeast Asian nation, under a new trade strategy that emphasises quick, industry-specific deals.
* COMMODITIES: Oil prices nudged higher, gold prices touched a three-week high, and copper prices on the London Metal Exchange and the Shanghai Futures Exchange were rangebound on Monday.
* For more on the factors affecting European stocks, please click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB
(Compiled by Nithyashree R B and Ankita Bora in Bengaluru)
((NithyashreeRB@thomsonreuters.com))